9,582 Shares in Astera Labs, Inc. $ALAB Acquired by Geneva Partners LLC

Geneva Partners LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 9,582 shares of the company’s stock, valued at approximately $1,876,000.

A number of other hedge funds also recently modified their holdings of ALAB. Arete Wealth Advisors LLC boosted its position in shares of Astera Labs by 57.0% in the third quarter. Arete Wealth Advisors LLC now owns 9,815 shares of the company’s stock worth $1,922,000 after buying an additional 3,565 shares during the period. American Century Companies Inc. boosted its position in Astera Labs by 754.8% during the 3rd quarter. American Century Companies Inc. now owns 280,296 shares of the company’s stock worth $54,882,000 after acquiring an additional 247,505 shares during the period. Rafferty Asset Management LLC acquired a new stake in Astera Labs during the 3rd quarter worth about $209,599,000. Ninepoint Partners LP purchased a new position in Astera Labs during the 3rd quarter valued at about $110,000. Finally, Integrated Financial Solutions Inc. acquired a new position in shares of Astera Labs in the 3rd quarter valued at about $2,198,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Analyst Ratings Changes

Several analysts recently commented on the stock. Raymond James Financial began coverage on shares of Astera Labs in a report on Friday, November 21st. They set a “hold” rating for the company. Jefferies Financial Group reiterated a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Stifel Nicolaus lifted their target price on shares of Astera Labs from $185.00 to $200.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Citigroup lowered their price target on shares of Astera Labs from $275.00 to $250.00 and set a “buy” rating on the stock in a report on Wednesday, February 11th. Finally, BNP Paribas Exane began coverage on shares of Astera Labs in a research note on Thursday, November 20th. They issued an “outperform” rating on the stock. Fourteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $192.89.

Astera Labs Stock Down 4.7%

NASDAQ:ALAB opened at $118.83 on Monday. The company’s 50 day moving average is $158.18 and its 200-day moving average is $172.31. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The firm has a market cap of $20.23 billion, a price-to-earnings ratio of 97.40, a P/E/G ratio of 2.34 and a beta of 1.50.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. Astera Labs’s quarterly revenue was up 91.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Research analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, COO Sanjay Gajendra sold 94,971 shares of the stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the completion of the sale, the chief operating officer owned 1,531,301 shares in the company, valued at $189,590,376.81. This represents a 5.84% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Jitendra Mohan sold 94,971 shares of the firm’s stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $11,758,359.51. Following the completion of the sale, the chief executive officer directly owned 1,452,739 shares in the company, valued at $179,863,615.59. This trade represents a 6.14% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 206,792 shares of company stock valued at $25,602,869. 12.50% of the stock is owned by company insiders.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.